beta cell

(redirected from Beta-cell)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Beta-cell: Islet of Langerhans

beta cell

n.
1. Any of the insulin-producing cells of the islets of Langerhans in the pancreas.
2. Any of the basophilic chromophil cells located in the anterior lobe of the pituitary gland.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

be′ta cell`


n.
a cell in the islets of Langerhans that produces and secretes insulin.
[1925–30]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.beta cell - a cell that produces insulin in the isles of Langerhans in the pancreas
cell - (biology) the basic structural and functional unit of all organisms; they may exist as independent units of life (as in monads) or may form colonies or tissues as in higher plants and animals
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
LOS ANGELES - New ways to preserve beta-cell function in youth with impaired glucose tolerance or recendy diagnosed type 2 diabetes mellitus (T2DM) are needed, because neither metformin alone nor metformin plus glargine are making a dent.
This finding challenges the previous paradigm that beta-cell function is irreversibly lost in patients with type 2 diabetes.
Type 2 diabetes is characterized by a progressive decline in beta-cell function and chronic insulin resistance (Butler et al., 2003).
Staffers, "Minireview: meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion," Molecular Endocrinology (Baltimore, Md.), vol.
These cells are well characterized and can provide physiologically relevant responses that are beneficial for modeling diabetes and beta-cell function, encouraging breakthroughs that advance research in personalized and regenerative medicine.
The report also provides strategic insights on medicines that are likely to have an impact on beta-cell protection treatment space and potentially alter standards of care in the foreseeable future.
Dynamics of beta-cell mass in the growing rat pancreas: Estimation with a simple mathematical model.
Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications.
M2 PHARMA-August 7, 2014-Biomarker testing of IR, pancreatic beta-cell dysfunction provides earlier detection of diabetes risk
Alvin Powers, M.D., the paper's senior author and director of the Vanderbilt Diabetes Center, said that the study "provides clues to how we might learn what signals promote beta-cell regeneration in type 1 and type 2 diabetes."
Although beta-cell mass is markedly diminished in longstanding type 1 diabetics, residual beta cells can be detected and new beta-cell formation may occur in these patients several decades after the disease onset [2].